Abstract 15945: Nationwide Inpatient Outcomes of Pericardial Tamponade in Patients With Autoimmune Diseases

IntroductionPericardial tamponade (PT) is associated with significant morbidity and mortality. The impact of autoimmune diagnosis on the outcomes of PT is not well studied. Therefore, we sought to study the trend and outcomes of PT with and without autoimmune diagnosis.MethodsUsing the National Inpa...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A15945-A15945
Main Authors: Furqan, Muhammad M, Al-Khadra, Yasser, Chahine, Johnny, Khayata, Mohamed, Verma, Beni R, Ala, Chandra K, Cremer, Paul, Alraies, M Chadi, Klein, Allan L
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionPericardial tamponade (PT) is associated with significant morbidity and mortality. The impact of autoimmune diagnosis on the outcomes of PT is not well studied. Therefore, we sought to study the trend and outcomes of PT with and without autoimmune diagnosis.MethodsUsing the National Inpatient Sampling (NIS) database from 2002 to 2014 we identified all adult patients with PT. Primary outcome was inpatient mortality while the secondary outcomes were pericardiocentesis, pericardial window, and length of stay (LOS).ResultsA total of 120,041 patients had the diagnosis of PT, out of which 5,114 (4.3%) had autoimmune disease. Patients with autoimmune diseases were younger (58 [43-68] vs 63 [52-74] years, p
ISSN:0009-7322
1524-4539
DOI:10.1161/circ.140.suppl_1.15945